New Radionuclides for Personalized Medicine

被引:1
|
作者
Zherebchevsky V.I. [1 ]
Alekseev I.E. [2 ]
Lazareva T.V. [1 ]
Maltsev N.A. [1 ]
Nauruzbayev D.K. [1 ]
Nesterov D.G. [1 ]
Prokofiev N.A. [1 ]
Rahmatullina A.R. [1 ]
Torilov S.Y. [1 ]
机构
[1] St. Petersburg State University, St. Petersburg
[2] Khlopin Radium Institute, St. Petersburg
基金
俄罗斯基础研究基金会;
关键词
D O I
10.3103/S1062873821100282
中图分类号
学科分类号
摘要
Abstract: The study of the processes and mechanisms of the medium group mass nuclear systems formation (formed in reactions with protons) has both an important fundamental and practical significance. These tasks are especially important for the production of medical radionuclides, which are used for the effective early diagnosis and treatment of the various cancers. Combining the methods of radionuclide imaging with the methods of radionuclide therapy (therapy plus diagnostics—theranostics), it is possible to implement unique methods of non-surgical treatment of tumors with their precise visualization and minimal side effects. Therefore, in this work the experimental and theoretical studies of the nuclear reaction excitation functions with targets: 117Sn and 119Sn in the proton energy range of 6–18 MeV are carried out. Cross sections of the formation of antimony radionuclides are obtained for these reactions, and the mechanisms of such reactions are analyzed. Antimony radionuclides are promising for use in theranostics. © 2021, Allerton Press, Inc.
引用
收藏
页码:1128 / 1135
页数:7
相关论文
共 50 条
  • [41] PHARMACOGENOMICS: TOWARDS A NEW ERA OF PERSONALIZED MEDICINE IN PSYCHIATRY?
    Mueller, Daniel
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S717 - S718
  • [42] Theranostics and artificial intelligence: new frontiers in personalized medicine
    Bilgin, Gokce Belge
    Bilgin, Cem
    Burkett, Brian J.
    Orme, Jacob J.
    Childs, Daniel S.
    Thorpe, Matthew P.
    Halfdanarson, Thorvardur R.
    Johnson, Geoffrey B.
    Kendi, Ayse Tuba
    Sartor, Oliver
    THERANOSTICS, 2024, 14 (06): : 2367 - 2378
  • [43] Sarcoidosis: proteomics and new perspectives for improving personalized medicine
    Landi, Claudia
    Carleo, Alfonso
    Cillis, Giuseppe
    Rottoli, Paola
    EXPERT REVIEW OF PROTEOMICS, 2018, 15 (10) : 829 - 835
  • [44] A new era of personalized medicine for cystic fibrosis - at last!
    Quon, Bradley S.
    Wilcox, Pearce G.
    CANADIAN RESPIRATORY JOURNAL, 2015, 22 (05) : 257 - 260
  • [45] New opportunities of dendrimers for theranostic approaches to personalized medicine
    Majoral, Jean-Pierre
    Shi, Xiangyang
    Mignani, Serge
    SCIENCE CHINA-MATERIALS, 2018, 61 (11) : 1365 - 1366
  • [46] New opportunities of dendrimers for theranostic approaches to personalized medicine
    Jean-Pierre Majoral
    Xiangyang Shi
    Serge Mignani
    Science China Materials, 2018, 61 : 1365 - 1366
  • [47] Clinical Applications of Personalized Medicine: A New Paradigm and Challenge
    Di Sanzo, Mariantonia
    Cipolloni, Luigi
    Borro, Marina
    La Russa, Raffaele
    Santurro, Alessandro
    Scopetti, Matteo
    Simmaco, Maurizio
    Frati, Paola
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2017, 18 (03) : 194 - 203
  • [48] Discovery of new treatments in the context of delivering personalized medicine
    Holgate, Stephen
    Palotie, Aarno
    PERSONALIZED MEDICINE, 2012, 9 (02) : 101 - 104
  • [49] The new era of personalized medicine: 10 years later
    Jorgensen, Jan Trost
    Winther, Henrik
    PERSONALIZED MEDICINE, 2009, 6 (04) : 423 - 428
  • [50] Circulating nucleosomes: a new addition to the personalized medicine toolkit
    Holdenrieder, Stefan
    PERSONALIZED MEDICINE, 2014, 11 (06) : 565 - 568